Related Experiment Video
Updated: Oct 9, 2025

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
Published on: November 27, 2017
Capturing Pluripotency and Beyond
Chih-Yu Yeh1, Wei-Han Huang1, Hung-Chi Chen1,2
1Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Insights
Embryonic stem cells (ESCs) can achieve expanded pluripotency, mimicking early embryo cells. Understanding these potency states in ESCs and epiblasts clarifies mammalian development.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Epigenetics
Background:
- Cell lineage specification begins with pluripotent epiblasts in early embryos.
- Embryonic stem cells (ESCs) in vitro model the self-renewal and differentiation of epiblasts.
- Totipotency and expanded pluripotency are key developmental states, with recent insights into their characteristics.
Purpose of the Study:
- To review the acquisition of epiblast identity during embryogenesis.
- To compare pluripotent fates and beyond in embryonic stem cells (ESCs) and their in vivo counterparts.
- To elucidate the molecular mechanisms underlying transitions between different stem cell potency states.
Main Methods:
- Comparative analysis of mouse and human pluripotent stem cells (PSCs).
- Review of recent studies on epiblast development and ESC properties.
- Examination of molecular roadmaps governing potency state transitions.
Main Results:
- A subset of ESCs exhibits expanded developmental potential, resembling two-cell embryo blastomeres (2CLCs).
- Reprogramming ESCs generates expanded/extended pluripotent stem cells (EPSCs) with unique properties.
- Molecular pathways driving potency state changes are increasingly understood.
Conclusions:
- Understanding potency states in epiblasts and ESCs is crucial for deciphering mammalian development.
- Comparing potency network components across species offers insights into developmental differences.
- Recent findings advance the comprehension of stem cell plasticity and developmental potential.
Abstract:
During the development of a multicellular organism, the specification of different cell lineages originates in a small group of pluripotent cells, the epiblasts, formed in the preimplantation embryo. The pluripotent epiblast is protected from premature differentiation until exposure to inductive cues in strictly controlled spatially and temporally organized patterns guiding fetus formation. Epiblasts cultured in vitro are embryonic stem cells (ESCs), which recapitulate the self-renewal and lineage specification properties of their endogenous counterparts. The characteristics of totipotency, although less understood than pluripotency, are becoming clearer. Recent studies have shown that a minor ESC subpopulation exhibits expanded developmental potential beyond pluripotency, displaying a characteristic reminiscent of two-cell embryo blastomeres (2CLCs). In addition, reprogramming both mouse and human ESCs in defined media can produce expanded/extended pluripotent stem cells (EPSCs) similar to but different from 2CLCs. Further, the molecular roadmaps driving the transition of various potency states have been clarified. These recent key findings will allow us to understand eutherian mammalian development by comparing the underlying differences between potency network components during development. Using the mouse as a paradigm and recent progress in human PSCs, we review the epiblast's identity acquisition during embryogenesis and their ESC counterparts regarding their pluripotent fates and beyond.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Maintenance of the ES Cell State
Induced Pluripotent Stem Cells
Methods of Nuclear Reprogramming
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Multipotency of Hematopoietic Stem Cells

